159 filings
Page 5 of 8
8-K
k5ak3
7 Feb 06
Entry into a Material Definitive Agreement
12:00am
8-K
msgtyfec23bbd jl
23 Jan 06
Other Events
12:00am
8-K
39tm875875z1 pwf94iq
10 Jan 06
Oscient Pharmaceuticals Provides Preliminary Revenues for Fourth Quarter and Fiscal Year 2005
12:00am
8-K/A
vss4ri ezw
29 Dec 05
Entry into a Material Definitive Agreement
12:00am
8-K
0z5wiwl nvwqw4q1bz
27 Dec 05
Entry into a Material Definitive Agreement
12:00am
8-K
2hnqpvgwynv
21 Dec 05
Other Events
12:00am
8-K
pknkq
19 Dec 05
Other Events
12:00am
8-K
rozsn
12 Dec 05
Other Events
12:00am
8-K
8v6ee6oqilit9rkc 4zv
22 Nov 05
Oscient Pharmaceuticals Submits sNDA to FDA for Five-Day Treatment of New Indications for FACTIVE® Tablets
12:00am
8-K
tpu83 oadi
4 Nov 05
Oscient Pharmaceuticals Reports Financial Results for Third Quarter of 2005
12:00am
8-K
z4uk8852034tjhur1p1
1 Nov 05
Oscient Pharmaceuticals to Present Clinical Data on FACTIVE® Tablets at CHEST 2005
12:00am
8-K
ret62jw9ioehnv02
19 Sep 05
Full Results Released from Phase III Trial Comparing Five-Day and Seven-Day Treatment
12:00am
8-K
uavn2cotxp15
3 Aug 05
Oscient Pharmaceuticals Reports Financial Results for Second Quarter of 2005
12:00am
8-K
ur4fhf
20 Jul 05
Oscient Pharmaceuticals Announces Transition of Chairman of Board
12:00am
8-K
ojlikslyd6tqussn4dz
7 Jun 05
Other Events
12:00am
8-K
3upik0b ifrb8
6 Jun 05
Other Events
12:00am
8-K
879lxh
3 May 05
Oscient Pharmaceuticals Reports Financial Results for First Quarter
12:00am
8-K
karaapjdfa
13 Apr 05
Entry into a Material Definitive Agreement
12:00am
8-K
1ek0s1i
6 Apr 05
Oscient Pharmaceuticals and LG Life Sciences Amend FACTIVE License Agreement
12:00am
8-K
9yi7ygi4ti87cil
6 Apr 05
Oscient Pharmaceuticals Provides Preliminary Results for First Quarter
12:00am